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Our Creative Inquiry team is researching the anti-tumor 
potential of compounds isolated from Physalis peruviana 
(poha) fruit. CellTiter 96 Aqueous Non-radiative Cell 
Proliferation Assays (Promega, 2012) were performed to 
screen the inhibitory activity of the compounds on human 
lung carcinoma A549 cells and breast cancer MDA-MB-
231 cells with the corresponding non-tumorigenic 
epithelial cell line NL20 and MCF-10A as controls. The 
cells were treated with compounds at concentrations of 
0μg/ml, 2μg/ml, 5μg/ml, and 20μg/ml and incubated for 
24, 48, and 72 hours.  
The results showed a greatest reduction in cell 
proliferation when treated with samples PPE37A, PPE28, 
PPE28A and PPE21_2P3P in the MDA-MB-231 cells as 
seen by a fold change less than 1. In the A549 cells, 
PPE28A and PPE21_2P3P presented promising results. 
The cells showed a sample dose dependence with the 
greatest decrease in proliferation for the higher treatment 
concentration (20ug/ml). The cell proliferation also showed 
a dependence on incubation time displaying a greatest 
reduction in proliferation on average when incubated for 72 
hours.  
Sample PPE21_2P3P at 72 hours was found to be the 
most promising sample for both cell lines and the assay was 
repeated to compare the cancer cell lines with normal cell 
lines. Ideally, the samples would decrease the cancer cell 
proliferation but remained ineffective on the normal cell 
lines. This trend was observed showing a fold change of 1 
in the MCF-10A and NL20 cells and a fold change below 1 
in the MDA-MB-231 and A549 cells treated with samples at 
concentration of 5ug/ml.   
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2. Cory, A.H. et al. (1991) Use of an aqueous soluble 
tetrazolium/formazan assay for cell growth assays in culture. 
Cancer Comm. 3, 207–12. 
3. Promega, 2012. CellTiter 96 AQueous Non-Radioactive Cell 
Proliferation Assay. Technical Bulletin n. 169. 
Results 
Results and Discussions 
Conclusion 
References 
The cells are first thawed and cultured by changing the media 
every two days. Once enough cells are cultured, they are plated 
in 96-well plates with 5,000 cells per well in 200ul of media. The 
plated cells are treated with 5ul of poha samples at 2ug/mL, 
5ug/mL and 20 ug/mL concentrations in triplicates. The controls 
include triplicates of media not treated with poha samples to 
detect contamination in the cells as well as triplicates of DMSO 
at 2ug/mL, 5ug/mL and 20 ug/mL concentrations which is used 
as a solvent for the samples. The DMSO control will serves as a 
baseline to determine if the poha sample had an effect on cell 
proliferation.  
The MTS cell proliferation assay is performed after 24, 48, 
and 72 hours of incubation and the absorbance of each plate is 
recorded. The average absorbance of the sample triplicates are 
taken and compared with the DMSO controls. The fold 
difference of each sample at the three time points are graphed. 
 
Native to South America, the Physalis peruviana (poha) plant has 
been widely introduced around the world particularly in Hawaii as a 
cultivated fruit, a medicinal plant and as an ornamental (CABI, 
2015). Poha has been claimed to be beneficial for a number of 
human diseases. However, there is very limited scientific evidence 
to support these claims. We believe that the confirmation of anti-
tumor potential of these poha derived compounds will provide 
cancer patients with more treatment options.  
The samples used by this project are extracts from the plant’s 
fruits produced by the collaboration laboratory at the University of 
Hawaii. The MTS assay performed determines the number of viable 
cells in proliferation. MTS is a substrate that can be reduced by 
cells into a formazan product that is soluble in tissue culture media 
(Promega, 2012). The amount of absorbance of the formazan 
product at 490nm is directly proportional to the number of living 
cells in culture (Cory, 1991). 
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Figure 1. Breast cancer cell proliferation after 24 hours of incubation. Figure 2. Breast cancer cell proliferation after 48 hours of incubation. Figure 3. Breast cancer cell proliferation after 72 hours of incubation. 
Figure 4. Breast cancer cell proliferation when 
treated with sample PPE37A at concentrations 
2ug/ml, 5ug/ml, and 20ug/ml. 
Figure 5. Breast cancer cell proliferation when 
treated with sample PPE28  at concentrations 
2ug/ml, 5ug/ml, and 20ug/ml. 
Figure 6. Breast cancer cell proliferation when 
treated with sample PPE28A  at concentrations 
2ug/ml, 5ug/ml, and 20ug/ml. 
Figure 7. Breast cancer cell proliferation when 
treated with sample PPE21_2P3P  at concentrations 
2ug/ml, 5ug/ml, and 20ug/ml. 
Figure 13. Normal and cancerous breast cell lines after treated with 
PPE21_2P3P and incubated for 72 hrs. MCF-10A serving as normal cell line 
control.  
Figure 14. Normal and cancerous lung cell lines after treated with 
PPE21_2P3P and incubated for 72 hrs. MCF-10A serving as normal cell line 
control.  
 
 The sample PPE21_2P3P with a concentration of 5 ug/mL was 
found to be the most promising sample for both the MDA-MB-231 and 
A549 cell lines. A fold change under 1 was observed for both of the cell 
lines, indicating a decrease in cell proliferation due to the sample. The 
sample PPE21_2P3P was also found to not inhibit cell proliferation of the 
normal cell lines MCF-10A and NL20. This is because a fold change 
above 1 was observed for both cell lines, indicating that cell proliferation 
was unaffected by the addition of the sample. Future directions include 
another round of sample PPE21_2P3P at 72 hours to confirm results and 
testing of the sample PPE21_2P3P on new cell lines.  
Figure 8: Lung cancer cell proliferation after 24 hours. Figure 9: Lung cancer cell proliferation after 48  hours. Figure 10: Lung cancer cell proliferation after 72  hours. 
Figure 11: Lung cancer cell proliferation when treated with 
sample PPE28A at concentrations 2ug/mL. 5 ug/mL and 20 
ug/mL. 
Figure 12: Lung cancer cell proliferation when treated with 
sample PPE21_2P3P at concentrations 2ug/mL. 5 ug/mL and 
20 ug/mL. 
